{"transactions":[{"id":310267,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-04-29T21:09:00.000Z","date":"2026-04-28","kind":"other","planned":false,"acquired":true,"shares":5314,"price":94.41,"value":501694.74,"ownership":{"direct":false,"nature":"Profit Sharing Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2026."}],"balance_after":17159,"source":{"system":"sec-edgar","filing":"0001783147-26-000009","document":"form4-04292026_090456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000009/form4-04292026_090456.xml","form_type":"4"}},{"id":312202,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:00:16.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":613,"price":115.58,"value":70850.54,"ownership":{"direct":true},"balance_after":104291,"source":{"system":"sec-edgar","filing":"0001783147-26-000007","document":"form4-03042026_010311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000007/form4-03042026_010311.xml","form_type":"4"}},{"id":312201,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:00:16.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":4630,"price":116.26,"value":538283.8,"ownership":{"direct":true},"balance_after":104904,"source":{"system":"sec-edgar","filing":"0001783147-26-000007","document":"form4-03042026_010311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000007/form4-03042026_010311.xml","form_type":"4"}},{"id":312699,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2026-02-26T23:43:36.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":57512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,170\non February 24, 2027, 19,171 on February 24, 2028, and 19,171 on February 24, 2029."}],"balance_after":57512,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":57512},"source":{"system":"sec-edgar","filing":"0001783147-26-000002","document":"form4-02262026_110230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000002/form4-02262026_110230.xml","form_type":"4"}},{"id":312698,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-02-26T23:43:36.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":13951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":109534,"source":{"system":"sec-edgar","filing":"0001783147-26-000002","document":"form4-02262026_110230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000002/form4-02262026_110230.xml","form_type":"4"}},{"id":324616,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-03-05T00:44:41.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":791,"price":138.17,"value":109292.47,"ownership":{"direct":true},"balance_after":95583,"source":{"system":"sec-edgar","filing":"0001415889-25-006786","document":"form4-03052025_120337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925006786/form4-03052025_120337.xml","form_type":"4"}},{"id":324615,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-03-05T00:44:41.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5598,"price":135.87,"value":760600.26,"ownership":{"direct":true},"balance_after":96374,"source":{"system":"sec-edgar","filing":"0001415889-25-006786","document":"form4-03052025_120337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925006786/form4-03052025_120337.xml","form_type":"4"}},{"id":325041,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2025-02-27T23:26:45.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":39896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,298 on February 25, 2026, 13,299 on February 25, 2027, and 13,299 on February 25, 2028."}],"balance_after":39896,"derivative":{"exercise_price":135.42,"exercise_date":"2026-02-25","expiration_date":"2035-02-24","underlying":"Common Shares","underlying_shares":39896},"source":{"system":"sec-edgar","filing":"0001415889-25-005897","document":"form4-02272025_110242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925005897/form4-02272025_110242.xml","form_type":"4"}},{"id":325040,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-02-27T23:26:45.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":10712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":101972,"source":{"system":"sec-edgar","filing":"0001415889-25-005897","document":"form4-02272025_110242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925005897/form4-02272025_110242.xml","form_type":"4"}},{"id":338503,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-03-05T00:09:44.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":676,"price":118.5,"value":80106.0,"ownership":{"direct":true},"balance_after":91260,"source":{"system":"sec-edgar","filing":"0001415889-24-006410","document":"form4-03052024_120338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924006410/form4-03052024_120338.xml","form_type":"4"}},{"id":338502,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-03-05T00:09:44.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":5862,"price":120.05,"value":703733.1,"ownership":{"direct":true},"balance_after":91936,"source":{"system":"sec-edgar","filing":"0001415889-24-006410","document":"form4-03052024_120338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924006410/form4-03052024_120338.xml","form_type":"4"}},{"id":339292,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2024-02-23T22:38:26.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":39734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,244 on February 21, 2025, 13,245 on February 21, 2026, and 13,245 on February 21, 2027."}],"balance_after":39734,"derivative":{"exercise_price":116.98,"exercise_date":"2025-02-21","expiration_date":"2034-02-20","underlying":"Common Shares","underlying_shares":39734},"source":{"system":"sec-edgar","filing":"0001415889-24-005105","document":"form4-02232024_100217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924005105/form4-02232024_100217.xml","form_type":"4"}},{"id":339291,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-02-23T22:38:26.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":10574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":97798,"source":{"system":"sec-edgar","filing":"0001415889-24-005105","document":"form4-02232024_100217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924005105/form4-02232024_100217.xml","form_type":"4"}},{"id":352004,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:45:37.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":717,"price":100.77,"value":72252.09,"ownership":{"direct":true},"balance_after":87224,"source":{"system":"sec-edgar","filing":"0001415889-23-003912","document":"form4-03032023_120314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003912/form4-03032023_120314.xml","form_type":"4"}},{"id":352003,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:45:37.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":5926,"price":99.77,"value":591237.02,"ownership":{"direct":true},"balance_after":87941,"source":{"system":"sec-edgar","filing":"0001415889-23-003912","document":"form4-03032023_120314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003912/form4-03032023_120314.xml","form_type":"4"}},{"id":352745,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2023-02-23T00:14:13.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":48344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,114 on February 17, 2024, 16,115 on February 17, 2025, and 16,115 on February 17, 2026."}],"balance_after":48344,"derivative":{"exercise_price":106.24,"exercise_date":"2024-02-17","expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":48344},"source":{"system":"sec-edgar","filing":"0001415889-23-003057","document":"form4-02232023_120200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003057/form4-02232023_120200.xml","form_type":"4"}},{"id":352744,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-02-23T00:14:13.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":12259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":93867,"source":{"system":"sec-edgar","filing":"0001415889-23-003057","document":"form4-02232023_120200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003057/form4-02232023_120200.xml","form_type":"4"}},{"id":359177,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-08-03T16:27:22.000Z","date":"2022-08-01","kind":"tax_withholding","acquired":false,"shares":1245,"price":108.84,"value":135505.8,"ownership":{"direct":true},"balance_after":81608,"source":{"system":"sec-edgar","filing":"0001415889-22-008158","document":"form4-08032022_090813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922008158/form4-08032022_090813.xml","form_type":"4"}},{"id":364698,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:52:57.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":4112,"price":122.41,"value":503349.92,"ownership":{"direct":true},"balance_after":82853,"source":{"system":"sec-edgar","filing":"0001415889-22-002197","document":"form4-03022022_040347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002197/form4-03022022_040347.xml","form_type":"4"}},{"id":365275,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2022-02-24T01:23:45.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":73696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,565 on February 18, 2023, 24,565 on February 18, 2024, and 24,566 on February 18, 2025."}],"balance_after":73696,"derivative":{"exercise_price":117.58,"exercise_date":"2023-02-18","expiration_date":"2032-02-17","underlying":"Common Shares","underlying_shares":73696},"source":{"system":"sec-edgar","filing":"0001415889-22-001742","document":"form4-02232022_050234.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001742/form4-02232022_050234.xml","form_type":"4"}},{"id":365274,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:23:45.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":400,"price":119.3067,"value":47722.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.3003 to $119.3100, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":86965,"source":{"system":"sec-edgar","filing":"0001415889-22-001742","document":"form4-02232022_050234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001742/form4-02232022_050234.xml","form_type":"4"}},{"id":365273,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:23:45.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":793,"price":116.79,"value":92614.47,"ownership":{"direct":true},"balance_after":87365,"source":{"system":"sec-edgar","filing":"0001415889-22-001742","document":"form4-02232022_050234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001742/form4-02232022_050234.xml","form_type":"4"}},{"id":365272,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:23:45.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":15813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":88158,"source":{"system":"sec-edgar","filing":"0001415889-22-001742","document":"form4-02232022_050234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001742/form4-02232022_050234.xml","form_type":"4"}},{"id":372833,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-08-03T21:40:34.000Z","date":"2021-08-01","kind":"tax_withholding","acquired":false,"shares":1245,"price":120.98,"value":150620.1,"ownership":{"direct":true},"balance_after":72345,"source":{"system":"sec-edgar","filing":"0001415889-21-003773","document":"form4-08032021_020823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921003773/form4-08032021_020823.xml","form_type":"4"}},{"id":379013,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:44:07.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":2116,"price":121.58,"value":257263.28,"ownership":{"direct":true},"balance_after":73590,"source":{"system":"sec-edgar","filing":"0001415889-21-001210","document":"form4-03022021_040343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001210/form4-03022021_040343.xml","form_type":"4"}},{"id":379657,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-02-24T00:05:01.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":69266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,088 on February 19, 2022, 23,089 on February 19, 2023, and 23,089 on February 19, 2024."}],"balance_after":69266,"derivative":{"exercise_price":124.04,"exercise_date":"2022-02-19","expiration_date":"2031-02-18","underlying":"Common Shares","underlying_shares":69266},"source":{"system":"sec-edgar","filing":"0001415889-21-000897","document":"form4-02232021_040247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000897/form4-02232021_040247.xml","form_type":"4"}},{"id":379656,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-24T00:05:01.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":400,"price":121.835,"value":48734.0,"ownership":{"direct":true},"balance_after":75706,"source":{"system":"sec-edgar","filing":"0001415889-21-000897","document":"form4-02232021_040247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000897/form4-02232021_040247.xml","form_type":"4"}},{"id":379655,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-24T00:05:01.000Z","date":"2021-02-22","kind":"tax_withholding","acquired":false,"shares":780,"price":123.04,"value":95971.2,"ownership":{"direct":true},"balance_after":76106,"source":{"system":"sec-edgar","filing":"0001415889-21-000897","document":"form4-02232021_040247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000897/form4-02232021_040247.xml","form_type":"4"}},{"id":379654,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-24T00:05:01.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":13513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":76886,"source":{"system":"sec-edgar","filing":"0001415889-21-000897","document":"form4-02232021_040247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000897/form4-02232021_040247.xml","form_type":"4"}},{"id":379928,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-18T22:57:35.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":505,"price":128.49,"value":64887.45,"ownership":{"direct":true},"balance_after":63373,"source":{"system":"sec-edgar","filing":"0001415889-21-000751","document":"form4-02182021_020211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000751/form4-02182021_020211.xml","form_type":"4"}},{"id":379927,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-18T22:57:35.000Z","date":"2021-02-16","kind":"tax_withholding","acquired":false,"shares":1009,"price":128.23,"value":129384.07,"ownership":{"direct":true},"balance_after":63878,"source":{"system":"sec-edgar","filing":"0001415889-21-000751","document":"form4-02182021_020211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000751/form4-02182021_020211.xml","form_type":"4"}},{"id":387624,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-08-04T21:15:03.000Z","date":"2020-08-01","kind":"tax_withholding","acquired":false,"shares":1244,"price":100.64,"value":125196.16,"ownership":{"direct":true},"balance_after":64887,"source":{"system":"sec-edgar","filing":"0001179110-20-008703","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020008703/edgar.xml","form_type":"4"}},{"id":394488,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2020-02-25T22:29:12.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":87334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 29,111 on February 21, 2021, 29,111 on February 21, 2022, and 29,112 on February 21, 2023."}],"balance_after":87334,"derivative":{"exercise_price":87.72,"exercise_date":"2021-02-21","expiration_date":"2030-02-20","underlying":"Common shares","underlying_shares":87334},"source":{"system":"sec-edgar","filing":"0001179110-20-002281","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002281/edgar.xml","form_type":"4"}},{"id":394487,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-25T22:29:12.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":400,"price":84.93,"value":33972.0,"ownership":{"direct":true},"balance_after":66131,"source":{"system":"sec-edgar","filing":"0001179110-20-002281","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002281/edgar.xml","form_type":"4"}},{"id":394486,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-25T22:29:12.000Z","date":"2020-02-22","kind":"tax_withholding","acquired":false,"shares":780,"price":87.45,"value":68211.0,"ownership":{"direct":true},"balance_after":66531,"source":{"system":"sec-edgar","filing":"0001179110-20-002281","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002281/edgar.xml","form_type":"4"}},{"id":394485,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-25T22:29:12.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":14326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":67311,"source":{"system":"sec-edgar","filing":"0001179110-20-002281","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002281/edgar.xml","form_type":"4"}},{"id":394919,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-19T22:53:59.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":1019,"price":88.97,"value":90660.43,"ownership":{"direct":true},"balance_after":52985,"source":{"system":"sec-edgar","filing":"0001179110-20-001897","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020001897/edgar.xml","form_type":"4"}},{"id":394918,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-19T22:53:59.000Z","date":"2020-02-17","kind":"tax_withholding","acquired":false,"shares":1004,"price":89.66,"value":90018.64,"ownership":{"direct":true},"balance_after":54004,"source":{"system":"sec-edgar","filing":"0001179110-20-001897","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020001897/edgar.xml","form_type":"4"}},{"id":394917,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-19T22:53:59.000Z","date":"2020-02-16","kind":"tax_withholding","acquired":false,"shares":1020,"price":89.66,"value":91453.2,"ownership":{"direct":true},"balance_after":55008,"source":{"system":"sec-edgar","filing":"0001179110-20-001897","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020001897/edgar.xml","form_type":"4"}},{"id":401095,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2019-08-05T21:15:19.000Z","date":"2019-08-01","kind":"grant","acquired":true,"shares":60912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,304 on August 1, 2020, 20,304 on August 1, 2021, and 20,304 on August 1, 2022."}],"balance_after":60912,"derivative":{"exercise_price":86.86,"exercise_date":"2020-08-01","expiration_date":"2029-07-31","underlying":"Common shares","underlying_shares":60912},"source":{"system":"sec-edgar","filing":"0001179110-19-009136","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019009136/edgar.xml","form_type":"4"}},{"id":401094,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-08-05T21:15:19.000Z","date":"2019-08-01","kind":"grant","acquired":true,"shares":8426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":56028,"source":{"system":"sec-edgar","filing":"0001179110-19-009136","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019009136/edgar.xml","form_type":"4"}}]}